FDA's New Tobacco Scheme, And Its Legislative Underpinnings, May Go Up In Smoke - Forbes
FDA was to create a path to enable cigarette makers to transition away from smoked tobacco and win government approval of consumable products that used tobacco but presumably harbored less, and perhaps even none of the health risks posed by smoking. When this quid pro quo was pushed through Congress, the industrys critics and allies each positioned it as a win-win. But it was dependent on FDA being able to establish and maintain a regulatory path that let tobacco get approval for new products that posed a reduced harm over traditional smoked cigarettes.
The tobacco industrys critics are trying to impede a critical first step that FDA must take in creating that new regulatory architecture. The ability to fulfill all of the laws goals is on the line.